DCMM
AGN

DG Capital Management (Massachusetts)’s Allergan plc AGN Stock Holding History

DG Capital Management (Massachusetts)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.25M Sell
5,413
-1,440
-21% -$352K 1.23% 36
2016
Q2 		$1.58M Buy
6,853
+1,605
+31% +$370K 1.69% 23
2016
Q1 		$1.41M Sell
5,248
-2,585
-33% -$740K 1.38% 36
2015
Q4 		$2.45M Sell
7,833
-5,650
-42% -$1.68M 2.18% 16
2015
Q3 		$3.67M Buy
13,483
+2,595
+24% +$797K 2.47% 10
2015
Q2 		$3.3M Buy
10,888
+90
+0.8% +$26.8K 1.99% 17
2015
Q1 		$3.21M Sell
10,798
-1,895
-15% -$540K 1.94% 20
2014
Q4 		$3.27M Buy
12,693
+1,220
+11% +$305K 1.89% 21
2014
Q3 		$2.77M Sell
11,473
-2,935
-20% -$657K 1.69% 24
2014
Q2 		$3.21M Buy
14,408
+1,373
+11% +$284K 1.83% 21
2014
Q1 		$2.68M Buy
+13,035
New +$2.58M 1.59% 34

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

DG Capital Management (Massachusetts)'s AGN Position: Q3 2016 in Review

DG Capital Management (Massachusetts) reduced its Allergan plc (AGN) stake by 21% in Q3 2016, selling an estimated $352K and leaving 5,413 shares worth $1.25M. The position accounts for 1.23% of the portfolio, ranked #36.

DG Capital Management (Massachusetts) first reported a position in AGN in Q1 2014 and has held it in 11 quarters since. The position peaked at $3.67M in Q3 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • DG Capital Management (Massachusetts) held 5,413 shares of Allergan plc worth $1.25M as of Q3 2016.
  • DG Capital Management (Massachusetts) sold 1,440 Allergan plc shares in Q3 2016, an estimated $352K.
  • Allergan plc made up 1.23% of DG Capital Management (Massachusetts)'s portfolio in Q3 2016, its #36 holding.
  • DG Capital Management (Massachusetts) first reported a position in Allergan plc in Q1 2014 and has held it in 11 quarters since.
  • DG Capital Management (Massachusetts)'s Allergan plc position peaked at $3.67M in Q3 2015.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q3 2016, filed 21 Oct 2016.